Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Condition(s):Primary Open Angle Glaucoma or Ocular HypertensionLast Updated:August 6, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Primary Open Angle Glaucoma or Ocular HypertensionLast Updated:August 6, 2019Completed
Condition(s):Primary Open Angle Glaucoma; Ocular HypertensionLast Updated:February 27, 2023Completed
Condition(s):Ocular Hypertension; Open Angle GlaucomaLast Updated:April 17, 2018Completed
Condition(s):Glaucoma, Open-Angle; Ocular HypertensionLast Updated:September 29, 2020Completed
Condition(s):Ocular Hypertension; Suspect GlaucomaLast Updated:March 28, 2022Completed
Condition(s):Open Angle Glaucoma; Ocular HypertensionLast Updated:October 19, 2020Completed
Condition(s):Corneal EdemaLast Updated:September 15, 2022Completed
Condition(s):Primary Open Angle Glaucoma or Ocular HypertensionLast Updated:December 23, 2019Completed
Condition(s):Fuchs’ Endothelial Dystrophy; Bullous KeratopathyLast Updated:February 12, 2021Completed
Condition(s):Fuchs’ Endothelial DystrophyLast Updated:February 6, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.